Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Hair loss is common in IBD patients, and some medications may lower the risk.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.